U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07443059) titled 'A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy Participants' on Feb. 25.
Brief Summary: This study is a single-dose, open-label, parallel design phase I clinical study to evaluate the PK characteristics and safety of single subcutaneous injection of ZT002 Injection in participants with different degrees of renal insufficiency and matched participants with normal renal function.
Study Start Date: April 10
Study Type: INTERVENTIONAL
Condition:
Overweight , Obesity
Intervention:
DRUG: Zovaglutide
Receive a single dose , SC
DRUG: Zovaglutide
Receive a single dose , SC
DRUG: Z...